Cargando…
Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population
Prostate cancer is responsible for major deaths globally after lung cancer. However, etiology of prostate cancer is still unknown. Individual risk and incidence of prostate cancer may result from the interaction of genetic susceptibility with exposure to environmental factors such as infectious agen...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532779/ https://www.ncbi.nlm.nih.gov/pubmed/23293472 http://dx.doi.org/10.4103/0971-6580.103681 |
_version_ | 1782254344829140992 |
---|---|
author | Dwivedi, Shailendra Goel, Apul Mandhani, Anil Khattri, Sanjay Pant, Kamlesh Kumar |
author_facet | Dwivedi, Shailendra Goel, Apul Mandhani, Anil Khattri, Sanjay Pant, Kamlesh Kumar |
author_sort | Dwivedi, Shailendra |
collection | PubMed |
description | Prostate cancer is responsible for major deaths globally after lung cancer. However, etiology of prostate cancer is still unknown. Individual risk and incidence of prostate cancer may result from the interaction of genetic susceptibility with exposure to environmental factors such as infectious agents, tobacco, occupational exposure, dietary carcinogens, and/or hormonal imbalances leading to injury of the prostate and to the development of chronic inflammation. About 30% of all human cancers are caused by tobacco smoking and inhaled pollutants. Inflammation is now regarded as an important hallmark of cancer. The present study has been aimed to explore the pro-inflammatory levels in prostate carcinoma patients by examining the serum levels of novel cytokine interleukin-18 (IL-18) expression in tobacco exposed population. A total of 578 (n = 284 biopsy proven prostate cancer patients, n = 294 controls with and without tobacco exposed population) were recruited. Serum IL-18 (Interleukin-18) level was done by ELISA. The IL-18 levels between cancer patients and controls within same mode tobacco exposure as tobacco smoking (overall) showed significant difference (P < 0.0001) and further we compared within stratified group, it significantly differ (P < 0.0001) in bidi and cigarette smoking than control non users. Furthermore, IL-18 levels in tobacco chewers (overall) with gutkha and khaini chewers showed significant difference (P < 0.01) than controls non users. Moreover, the IL-18 levels between cancer patients and controls with in of combined mode chewers smokers and alcohol (CSA), smokers with alcohol showed significant difference (P < 0.01) than controls. The IL-18 levels also differed significantly (P < 0.05) with smokers and chewers in higher stages of III and IV, and showed non significant with in lower stages. Tobacco exposure enhance the inflammation in prostate carcinoma patients in stratified group as it have been represented as a risk factors in various cancers, but this study provide further its role that seems to influence inflammation especially in prostate carcinoma. |
format | Online Article Text |
id | pubmed-3532779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35327792013-01-04 Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population Dwivedi, Shailendra Goel, Apul Mandhani, Anil Khattri, Sanjay Pant, Kamlesh Kumar Toxicol Int Original Article Prostate cancer is responsible for major deaths globally after lung cancer. However, etiology of prostate cancer is still unknown. Individual risk and incidence of prostate cancer may result from the interaction of genetic susceptibility with exposure to environmental factors such as infectious agents, tobacco, occupational exposure, dietary carcinogens, and/or hormonal imbalances leading to injury of the prostate and to the development of chronic inflammation. About 30% of all human cancers are caused by tobacco smoking and inhaled pollutants. Inflammation is now regarded as an important hallmark of cancer. The present study has been aimed to explore the pro-inflammatory levels in prostate carcinoma patients by examining the serum levels of novel cytokine interleukin-18 (IL-18) expression in tobacco exposed population. A total of 578 (n = 284 biopsy proven prostate cancer patients, n = 294 controls with and without tobacco exposed population) were recruited. Serum IL-18 (Interleukin-18) level was done by ELISA. The IL-18 levels between cancer patients and controls within same mode tobacco exposure as tobacco smoking (overall) showed significant difference (P < 0.0001) and further we compared within stratified group, it significantly differ (P < 0.0001) in bidi and cigarette smoking than control non users. Furthermore, IL-18 levels in tobacco chewers (overall) with gutkha and khaini chewers showed significant difference (P < 0.01) than controls non users. Moreover, the IL-18 levels between cancer patients and controls with in of combined mode chewers smokers and alcohol (CSA), smokers with alcohol showed significant difference (P < 0.01) than controls. The IL-18 levels also differed significantly (P < 0.05) with smokers and chewers in higher stages of III and IV, and showed non significant with in lower stages. Tobacco exposure enhance the inflammation in prostate carcinoma patients in stratified group as it have been represented as a risk factors in various cancers, but this study provide further its role that seems to influence inflammation especially in prostate carcinoma. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3532779/ /pubmed/23293472 http://dx.doi.org/10.4103/0971-6580.103681 Text en Copyright: © Toxicology International http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Dwivedi, Shailendra Goel, Apul Mandhani, Anil Khattri, Sanjay Pant, Kamlesh Kumar Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population |
title | Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population |
title_full | Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population |
title_fullStr | Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population |
title_full_unstemmed | Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population |
title_short | Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population |
title_sort | tobacco exposure may enhance inflammation in prostate carcinoma patients: an explorative study in north indian population |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532779/ https://www.ncbi.nlm.nih.gov/pubmed/23293472 http://dx.doi.org/10.4103/0971-6580.103681 |
work_keys_str_mv | AT dwivedishailendra tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation AT goelapul tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation AT mandhanianil tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation AT khattrisanjay tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation AT pantkamleshkumar tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation |